Effect of neuroserpin in a neonatal hypoxic-ischemic injury model ex vivo

Biological Research

Volumn 45, Issue 4, 2012, Pages 357-362

  Ma, Jiao ^a   Yu, Dan ^a,b   Tong, Yu ^a   Mao, Meng ^a,b  

^a SICHUAN UNIVERSITY   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

Author keywords

Excitotoxicity; Hypoxia ischemia; N methyl D aspartic; Neuroserpin; Tissue type plasminogen activator

Indexed keywords

DIZOCILPINE MALEATE; N METHYLASPARTIC ACID; NEUROPEPTIDE; NEUROPROTECTIVE AGENT; NEUROSERPIN; SERINE PROTEINASE INHIBITOR; TISSUE PLASMINOGEN ACTIVATOR;

ANIMAL; ARTICLE; CELL SURVIVAL; DRUG ANTAGONISM; DRUG EFFECT; FEMALE; HYPOXIC ISCHEMIC ENCEPHALOPATHY; IMMUNOHISTOCHEMISTRY; NERVE CELL; NEWBORN; PATHOLOGY; PREGNANCY; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT;

ANIMALS; ANIMALS, NEWBORN; CELL SURVIVAL; DIZOCILPINE MALEATE; FEMALE; HYPOXIA-ISCHEMIA, BRAIN; IMMUNOHISTOCHEMISTRY; N-METHYLASPARTATE; NEURONS; NEUROPEPTIDES; NEUROPROTECTIVE AGENTS; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SERPINS; TISSUE PLASMINOGEN ACTIVATOR;

EID: 84875329511     PISSN: 07169760     EISSN: 07176287     Source Type: Journal    
DOI: 10.4067/S0716-97602012000400005     Document Type: Article

References (35)

1. ADHAMI F, YU D, YIN W, SCHLOEMER A, BURNS KA, LIAO G, DEGEN JL, CHEN J, KUAN CY (2008) Deleterious effects of plasminogen activators in neonatal cerebral hypoxia-ischemia. Am J Pathol 172:1704--1716.
2. BENARROCH EE (2007) Tissue plasminogen activator: beyond thrombolysis. Neurology 69:799-802.
3. BERGER P, KOZLOV SV, CINELLI P, KRUGER SR, VOGT L, SONDEREGGER P (1999) Neuronal depolarization enhances the transcription of the neuronal serine protease inhibitor neuroserpin. Mol Cell Neurosci 14:455-467.
4. CINELLI P, MADANI R, TSUZUKI N, VALLET P, ARRAS M, ZHAO CN, OSTERWALDER T, RULICKE T, SONDEREGGER P (2001) Neuroserpin, a neuroprotective factor in focal ischemic stroke. Mol Cell Neurosci 18:443-457.
5. COLLEN D (2001) Ham-Wasserman lecture: role of the plasminogen system in fibrin-homeostasis and tissue remodeling. Hematology Am Soc Hematol Educ Program 2001:1-9.
6. DIRNAGL U, IADECOLA C, MOSKOWITZ MA (1999) Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci 22:391-397.
7. DISTEFANO G, PRATICO AD (2010) Actualities on molecular pathogenesis and repairing processes of cerebral damage in perinatal hypoxicischemic encephalopathy. Ital J Pediatr 36:63.
8. ECHEVERRY R, WU J, HAILE WB, GUZMAN J, YEPES M (2010) Tissue-type plasminogen activator is a neuroprotectant in the mouse hippocampus. J Clin Invest 120:2194-2205.
9. FERRIERO DM (2004) Neonatal brain injury. N Engl J Med 351:1985-1995.
10. HARUKUNI I, BHARDWAJ A (2006) Mechanisms of brain injury after global cerebral ischemia. Neurol Clin 24:1-21.
11. JOHNSTON MV (1995) Neurotransmitters and vulnerability of the developing brain. Brain Dev 17:301-306.
12. LEBEURRIER N, LIOT G, LOPEZ-ATALAYA JP, ORSET C, FERNÁNDEZ-MONREAL M, SONDEREGGER P, ALI C, VIVIEN D (2005) The brain-specific tissue-type plasminogen activator inhibitor, neuroserpin, protects neurons against excitotoxicity both in vitro and in vivo. Mol Cell Neurosci 30:552-558.
13. LEVINE RL, MOSONI L, BERLETT BS, STADTMAN ER (1996) Methionine residues as endogenous antioxidants in proteins. Proc Natl Acad Sci USA 93:15036-15040.
14. LIOT G, ROUSSEL BD, LEBEURRIER N, BENCHENANE K, LÓPEZ-ATALAYA JP, VIVIEN D, ALI C (2006) Tissue-type plasminogen activator rescues neurones from serum deprivation-induced apoptosis through a mechanism independent of its proteolytic activity. J Neurochem 98:1458-1464.
15. MOHSENIFAR A, LOTFI AS, RANJBAR B, ALLAMEH A, ZAKER F, HASANI L, KIA BE, HASANNIA S (2007) A study of the oxidationinduced conformational and functional changes in neuroserpin. Iran Biomed J 11:41-46.
16. MUJSCE DJ, CHRISTENSEN MA, VANNUCCI RC (1990) Cerebral blood flow and edema in perinatal hypoxic-ischemic brain damage. Pediatr Res 27:450-453.
17. MUNUSWAMY-RAMANUJAM G, DAI E, LIU L, SHNABEL M, SUN YM, BARTEE M, LOMAS DA, LUCAS AR (2010) Neuroserpin, a thrombolytic serine protease inhibitor (serpin), blocks transplant vasculopathy with associated modification of T-helper cell subsets. Thromb Haemost 103:545-555.
18. NICOLE O, DOCAGNE F, ALI C, MARGAILL I, CARMELIET P, MACKENZIE ET, VIVIEN D, BUISSON A (2001) The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling. Nat Med 7:59-64.
19. OSTERWALDER T,CONTARTESE J,STOECKLI E,KUHN T,SONDEREGGER P (1996) Neuroserpin, an axonally secreted serine protease inhibitor. EMBO J 15:2944-2953.
20. QIAN Z, GILBERT ME, COLICOS MA, KANDEL ER, KUHL D (1993) Tissueplasminogen activator is induced as an immediate-early gene during seizure, kindling and long-term potentiation. Nature 361:453-457.
21. RODRÍGUEZ-GONZÁLEZ R, AGULLA J, PEREZ-MATO M, SOBRINO T, CASTILLO J (2011) Neuroprotective effect of neuroserpin in rat primary cortical cultures after oxygen and glucose deprivation and tPA. Neurochem Int 58:337-344.
22. RODRÍGUEZ-GONZÁLEZ R, SOBRINO T, RODRÍGUEZ-YÁÑEZ M, MILLAN M, BREA D, MIRANDA E, MOLDES O, PÉREZ J, LOMAS DA, LEIRA R, DAVALOS A, CASTILLO J (2011) Association between neuroserpin and molecular markers of brain damage in patients with acute ischemic stroke. J Transl Med 9:58-65.
23. SADASIVAN S, ZHANG Z, LARNER SF, LIU MC, ZHENG W, KOBEISSY FH, HAYES RL, WANG KK (2010) Acute NMDA toxicity in cultured rat cerebellar granule neurons is accompanied by autophagy induction and late onset autophagic cell death phenotype. BMC Neurosci 11:21.
24. SHELDON RA, PARTRIDGE JC, FERRIERO DM (1992) Postischemic hyperglycemia is not protective to the neonatal rat brain. Ped Res 32:489-493.
25. TOWFIGHI J, MAUGER D, VANNUCCI RC, VANNUCCI SJ (1997) Influence of age on the cerebral lesions in an immature rat model of cerebral hypoxia-ischemia: a light microscopic study. Brain Res Dev Brain Res 100:149-160.
26. TSIRKA SE, GUALANDRIS A, AMARAL DG, STRICKLAND S (1995) Excitotoxin-induced neuronal degeneration and seizure are mediated by tissue plasminogen activator. Nature 377:340-344.
27. TSIRKA SE, BUGGE TH, DEGEN JL, STRICKLAND S (1997) Neuronal death in the central nervous system demonstrates a non-fibrin substrate for plasmin. Proc Natl Acad Sci USA 94:9779-9781.
28. VANNUCCI SJ, HAGBERG H (2004) Hypoxia-ischemia in the immature brain. J Exp Biol 207:3149-3154.
29. WANG YF, TSIRKA SE, STRICKLAND S, STIEG PE, SORIANO SG, LIPTON SA (1998) Tissue plasminogen activator (tPA) increases neuronal damage after focal cerebral ischemia in wild-type and tPA-deficient mice. Nat Med 4:228-231.
30. WU J, ECHEVERRY R, GUZMÁN J, YEPES M (2010) Neuroserpin protects neurons from ischemia-induced plasmin-mediated cell death independently of tissue-type plasminogen activator inhibition. Am J Pathol 177:2576-2584.
31. YANG D, NEMKUL N, SHEREEN A, JONE A, DUNN RS, LAWRENCE DA, LINDQUIST D, KUAN CY (2009) Therapeutic administration of plasminogen activator inhibitor-1 prevents hypoxic-ischemic brain injury in newborns. J Neurosci 29:8669-8674.
32. YEPES M, LAWRENCE DA (2004) Neuroserpin: a selective inhibitor of tissue-type plasminogen actovator in the central nervous syetem. Thromb Haemost 91:457-464.
33. YEPES M, SANDKVIST M, WONG MK, COLEMAN TA, SMITH E, COHAN SL, LAWRENCE DA (2000) Neuroserpin reduces cerebral infarct volume and protects neurons from ischemia-induced apoptosis. Blood 96:569--576.
34. ZHANG L, QU Y, YANG C, TANG J, ZHANG X, MAO M, MU D, FERRIERO D (2009) Signaling pathway involved in hypoxia-inducible factor-1alpha regulation in hypoxic-ischemic cortical neurons in vitro. Neurosci Lett 461:1-6.
35. ZHANG Z, ZHANG L, YEPES M, JIANG Q, LI Q, ARNIEGO P, COLEMAN TA, LAWRENCE DA, CHOPP M (2002) Adjuvant treatment with neuroserpin increases the therapeutic window for tissue-type plasminogen activator administration in a rat model of embolic stroke. Circulation 106:740-745.